In vitro selection of ketoconazole-pentamidine-resistant Leishmania (Viannia) braziliensis strains
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 233, 108206
Abstract
No abstract availableKeywords
Funding Information
- Universidad Industrial de Santander
This publication has 44 references indexed in Scilit:
- Leishmania donovani Develops Resistance to Drug CombinationsPLOS Neglected Tropical Diseases, 2012
- Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection ProtocolPLOS Neglected Tropical Diseases, 2012
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovaniAntimicrobial Agents and Chemotherapy, 2012
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New WorldActa Tropica, 2011
- Compensation of Fitness Costs and Reversibility of Antibiotic Resistance MutationsAntimicrobial Agents and Chemotherapy, 2010
- Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania speciesParasitology Research, 2010
- In vitro selection of Plasmodium falciparum drug-resistant parasite linesJournal of Antimicrobial Chemotherapy, 2009
- Characterizing the Effect of Pentamidine Isethionate on the Immune System Using Mouse Splenocytes as an Experimental ModelJournal of Immunotoxicology, 2007
- Resistance to Antimony and Treatment Failure in HumanLeishmania (Viannia)InfectionThe Journal of Infectious Diseases, 2006
- Resistance to Pentamidine in Leishmania mexicana Involves Exclusion of the Drug from the MitochondrionAntimicrobial Agents and Chemotherapy, 2002